p53 induces NF-κB activation by an IκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1

被引:218
作者
Bohuslav, J
Chen, LF
Kwon, H
Mu, YJ
Greene, WC
机构
[1] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
关键词
D O I
10.1074/jbc.M313509200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apoptosis induced by p53 has been proposed to involve activation of the transcription factor NF-kappaB. Here we describe the novel molecular mechanism through which p53 and DNA-damaging agents activate NF-kappaB. NF-kappaB induction by p53 does not occur through classical activation of the IkappaB kinases and degradation of IkappaBalpha. Rather, p53 expression stimulates the serine/threonine kinase ribosomal S6 kinase 1 (RSK1), which in turn phosphorylates the p65 subunit of NF-kappaB. The lower affinity of RSK1-phosphorylated p65 for its negative regulator, IkappaBalpha, decreases IkappaBalpha-mediated nuclear export of shuttling forms of NF-kappaB, thereby promoting the binding and action of NF-kappaB on cognate kappaB enhancers. These findings highlight a rather unusual pathway of NF-kappaB activation, which is utilized by the p53 tumor suppressor.
引用
收藏
页码:26115 / 26125
页数:11
相关论文
共 81 条
  • [1] Absence of mutations in the transforming growth factor-β inducible early gene 1, TIEG1, in pancreatic cancer
    Antonello, D
    Moore, PS
    Zamboni, G
    Falconi, M
    Scarpa, A
    [J]. CANCER LETTERS, 2002, 183 (02) : 179 - 183
  • [2] ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689
  • [3] Recruitment of p300/CBP in p53-dependent signal pathways
    Avantaggiati, ML
    Ogryzko, V
    Gardner, K
    Giordano, A
    Levine, AS
    Kelly, K
    [J]. CELL, 1997, 89 (07) : 1175 - 1184
  • [4] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [5] Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression
    Bauer, MKA
    Vogt, M
    Los, M
    Siegel, J
    Wessellborg, S
    Schulze-Osthoff, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) : 8048 - 8055
  • [6] EMBRYONIC LETHALITY AND LIVER DEGENERATION IN MICE LACKING THE RELA COMPONENT OF NF-KAPPA-B
    BEG, AA
    SHA, WC
    BRONSON, RT
    GHOSH, S
    BALTIMORE, D
    [J]. NATURE, 1995, 376 (6536) : 167 - 170
  • [7] Sequential DNA damage-independent and -dependent activation of NF-κB by UV
    Bender, K
    Göttlicher, M
    Whiteside, S
    Rahmsdorf, HJ
    Herrlich, P
    [J]. EMBO JOURNAL, 1998, 17 (17) : 5170 - 5181
  • [8] HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I TAX ASSOCIATES WITH AND IS NEGATIVELY REGULATED BY THE NF-KAPPA-B2 P100 GENE-PRODUCT - IMPLICATIONS FOR VIRAL LATENCY
    BERAUD, C
    SUN, SC
    GANCHI, P
    BALLARD, DW
    GREENE, WC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (02) : 1374 - 1382
  • [9] The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD
    Bernard, D
    Monte, D
    Vandenbunder, B
    Abbadie, C
    [J]. ONCOGENE, 2002, 21 (28) : 4392 - 4402
  • [10] PYRROLIDINE DITHIOCARBAMATE, A POTENT INHIBITOR OF NUCLEAR FACTOR KAPPA-B (NF-KAPPA-B) ACTIVATION, PREVENTS APOPTOSIS IN HUMAN PROMYELOCYTIC LEUKEMIA HL-60 CELLS AND THYMOCYTES
    BESSHO, R
    MATSUBARA, K
    KUBOTA, M
    KUWAKADO, K
    HIROTA, H
    WAKAZONO, Y
    LIN, YW
    OKUDA, A
    KAWAI, M
    NISHIKOMORI, R
    HEIKE, T
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 48 (10) : 1883 - 1889